• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study. 伴有原发性预防植入式心脏除颤器患者的竞争风险:全球电异质性与临床结局研究。
Heart Rhythm. 2021 Jun;18(6):977-986. doi: 10.1016/j.hrthm.2021.03.006. Epub 2021 Mar 6.
2
Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.通过评估植入式心脏复律除颤器患者的整体电不均一性心电图指标及临床结局来改善心脏性猝死风险分层:一项回顾性、多中心、队列研究的原理与设计
J Interv Card Electrophysiol. 2018 Jun;52(1):77-89. doi: 10.1007/s10840-018-0342-2. Epub 2018 Mar 14.
3
Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study.单形性与非单形性室性心律失常在植入式心脏复律除颤器一级预防患者中的竞争风险:全球电异质性和临床结局(GEHCO)研究。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae127.
4
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?肥厚型心肌病患者的一级预防植入式心脏转复除颤器——是否存在合适治疗的预测因素?
Heart Rhythm. 2021 Jan;18(1):63-70. doi: 10.1016/j.hrthm.2020.08.009. Epub 2020 Aug 12.
5
Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: Improve SCA clinical trial.在新兴国家中使用植入式心脏复律除颤器预防心源性猝死:改善 SCA 临床试验。
Heart Rhythm. 2020 Mar;17(3):468-475. doi: 10.1016/j.hrthm.2019.09.023. Epub 2019 Sep 24.
6
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.肥厚型心肌病患者皮下植入式心律转复除颤器中的适当和不适当电击:一项国际多中心研究。
Heart Rhythm. 2020 Jul;17(7):1107-1114. doi: 10.1016/j.hrthm.2020.02.008. Epub 2020 Feb 18.
7
Automated electrocardiographic quantification of myocardial scar in patients undergoing primary prevention implantable cardioverter-defibrillator implantation: Association with mortality and subsequent appropriate and inappropriate therapies.对行初级预防植入式心律转复除颤器患者进行自动心电图心肌瘢痕定量分析:与死亡率及随后的适当和不适当治疗的相关性。
Heart Rhythm. 2020 Oct;17(10):1664-1671. doi: 10.1016/j.hrthm.2020.05.016. Epub 2020 May 17.
8
Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.在心血管研究网络中接受初级预防植入式心脏除颤器的患者中,设备治疗。
J Am Heart Assoc. 2018 Mar 26;7(7):e008292. doi: 10.1161/JAHA.117.008292.
9
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用:基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
10
Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者一级预防植入型心律转复除颤器的年龄和结局。
Circulation. 2017 Nov 7;136(19):1772-1780. doi: 10.1161/CIRCULATIONAHA.117.028829. Epub 2017 Sep 6.

引用本文的文献

1
Electrical Heterogeneity in Hispanic Background Subpopulations: The HCHS/SOL.西班牙裔背景亚人群中的电不均一性:西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)
JACC Adv. 2024 Sep 11;3(12):101225. doi: 10.1016/j.jacadv.2024.101225. eCollection 2024 Dec.
2
Latent profiles of global electrical heterogeneity: the Hispanic Community Health Study/Study of Latinos.全球电不均一性的潜在概况:西班牙裔社区健康研究/拉丁裔研究
Eur Heart J Digit Health. 2024 Jul 8;5(5):611-621. doi: 10.1093/ehjdh/ztae048. eCollection 2024 Sep.
3
The Spatial Ventricular Gradient Is an Independent Predictor of Anthracycline-Associated Cardiotoxicity.空间心室梯度是蒽环类药物相关心脏毒性的独立预测因子。
JACC Adv. 2023 Mar 31;2(2):100269. doi: 10.1016/j.jacadv.2023.100269. eCollection 2023 Mar.
4
Electrocardiographic risk stratification in patients with a primary prophylactic implantable cardioverter defibrillator: can future arrhythmias correlating with sudden cardiac death be predicted?原发性预防性植入式心脏复律除颤器患者的心电图风险分层:与心源性猝死相关的未来心律失常能否被预测?
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae133.
5
Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study.单形性与非单形性室性心律失常在植入式心脏复律除颤器一级预防患者中的竞争风险:全球电异质性和临床结局(GEHCO)研究。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae127.
6
Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease.空间电生物标志物的遗传结构与心律失常及与心血管疾病的关系。
Nat Commun. 2023 Mar 14;14(1):1411. doi: 10.1038/s41467-023-36997-w.
7
The spatial ventricular gradient is associated with adverse outcomes in acute pulmonary embolism.空间心室梯度与急性肺栓塞的不良预后相关。
Ann Noninvasive Electrocardiol. 2023 May;28(3):e13041. doi: 10.1111/anec.13041. Epub 2023 Jan 24.
8
The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions.代谢综合征与心源性猝死风险的关系:最新证据与未来方向。
Eur J Clin Invest. 2022 Feb;52(2):e13693. doi: 10.1111/eci.13693. Epub 2021 Nov 8.
9
Reproducibility of global electrical heterogeneity measurements on 12-lead ECG: The Multi-Ethnic Study of Atherosclerosis.12 导联心电图全球电异质性测量的可重复性:动脉粥样硬化的多民族研究。
J Electrocardiol. 2021 Nov-Dec;69:96-104. doi: 10.1016/j.jelectrocard.2021.09.014. Epub 2021 Oct 2.
10
Detection and removal of pacing artifacts prior to automated analysis of 12-lead ECG.在自动分析 12 导联心电图之前检测和去除起搏伪迹。
Comput Biol Med. 2021 Jun;133:104396. doi: 10.1016/j.compbiomed.2021.104396. Epub 2021 Apr 19.

本文引用的文献

1
Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study.植入式心脏复律除颤器患者的心脏记忆特征:植入式心脏复律除颤器心脏记忆(CAMI)研究
J Innov Card Rhythm Manag. 2021 Feb 15;12(2):4395-4408. doi: 10.19102/icrm.2021.120204. eCollection 2021 Feb.
2
Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.再评估在原发性预防植入型心律转复除颤器接受者中快速室性心律失常时抗心动过速起搏的作用:来自 MADIT-RIT 的结果。
Heart Rhythm. 2021 Mar;18(3):399-403. doi: 10.1016/j.hrthm.2020.11.019. Epub 2020 Nov 21.
3
Global electrical heterogeneity associated with drug-induced torsades de pointes.与药物致尖端扭转型室性心动过速相关的全球电异质性。
Heart Rhythm. 2021 Jan;18(1):57-62. doi: 10.1016/j.hrthm.2020.07.038. Epub 2020 Aug 8.
4
Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease.简单的心电图测量可改善冠心病患者心律失常性猝死的预测。
Eur Heart J. 2020 Jun 1;41(21):1988-1999. doi: 10.1093/eurheartj/ehaa177.
5
Dynamic predictive accuracy of electrocardiographic biomarkers of sudden cardiac death within a survival framework: the Atherosclerosis Risk in Communities (ARIC) study.基于生存框架的心电图生物标志物对心源性猝死的动态预测准确性:动脉粥样硬化风险社区(ARIC)研究。
BMC Cardiovasc Disord. 2019 Nov 14;19(1):255. doi: 10.1186/s12872-019-1234-9.
6
Changes in global electrical heterogeneity associated with dofetilide, quinidine, ranolazine, and verapamil.与多非利特、奎尼丁、雷诺嗪和维拉帕米相关的全球电异质性变化。
Heart Rhythm. 2020 Mar;17(3):460-467. doi: 10.1016/j.hrthm.2019.09.017. Epub 2019 Sep 17.
7
Importance of the heart vector origin point definition for an ECG analysis: The Atherosclerosis Risk in Communities (ARIC) study.心向量起点定义对心电图分析的重要性:动脉粥样硬化风险社区(ARIC)研究。
Comput Biol Med. 2019 Jan;104:127-138. doi: 10.1016/j.compbiomed.2018.11.013. Epub 2018 Nov 17.
8
Vectorcardiogram in athletes: The Sun Valley Ski Study.运动员的心向量图:太阳谷滑雪研究
Ann Noninvasive Electrocardiol. 2019 May;24(3):e12614. doi: 10.1111/anec.12614. Epub 2018 Nov 7.
9
Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.通过评估植入式心脏复律除颤器患者的整体电不均一性心电图指标及临床结局来改善心脏性猝死风险分层:一项回顾性、多中心、队列研究的原理与设计
J Interv Card Electrophysiol. 2018 Jun;52(1):77-89. doi: 10.1007/s10840-018-0342-2. Epub 2018 Mar 14.
10
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会报告
Heart Rhythm. 2018 Oct;15(10):e190-e252. doi: 10.1016/j.hrthm.2017.10.035. Epub 2017 Oct 30.

伴有原发性预防植入式心脏除颤器患者的竞争风险:全球电异质性与临床结局研究。

Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study.

机构信息

Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Department of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon.

出版信息

Heart Rhythm. 2021 Jun;18(6):977-986. doi: 10.1016/j.hrthm.2021.03.006. Epub 2021 Mar 6.

DOI:10.1016/j.hrthm.2021.03.006
PMID:33684549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8169548/
Abstract

BACKGROUND

Global electrical heterogeneity (GEH) is associated with sudden cardiac death in the general population. Its utility in patients with systolic heart failure who are candidates for primary prevention (PP) implantable cardioverter-defibrillators (ICDs) is unclear.

OBJECTIVE

The purpose of this study was to investigate whether GEH is associated with sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies in patients with heart failure and PP ICDs.

METHODS

We conducted a multicenter retrospective cohort study. GEH was measured by spatial ventricular gradient (SVG) direction (azimuth and elevation) and magnitude, QRS-T angle, and sum absolute QRST integral on preimplant 12-lead electrocardiograms. Survival analysis using cause-specific hazard functions compared the strength of associations with 2 competing outcomes: sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies and all-cause death without appropriate ICD therapies.

RESULTS

We analyzed 2668 patients (mean age 63 ± 12 years; 624 (23%) female; 78% white; 43% nonischemic cardiomyopathy; left ventricular ejection fraction 28% ± 11% from 6 academic medical centers). After adjustment for demographic, clinical, device, and traditional electrocardiographic characteristics, SVG elevation (hazard ratio [HR] per 1SD 1.14; 95% confidence interval [CI] 1.04-1.25; P = .004), SVG azimuth (HR per 1SD 1.12; 95% CI 1.01-1.24; P = .039), SVG magnitude (HR per 1SD 0.75; 95% CI 0.66-0.85; P < .0001), and QRS-T angle (HR per 1SD 1.21; 95% CI 1.08-1.36; P = .001) were associated with appropriate ICD therapies. Sum absolute QRST integral had different associations in infarct-related cardiomyopathy (HR 1.29; 95% CI 1.04-1.60) and nonischemic cardiomyopathy (HR 0.78; 95% CI 0.62-0.96) (P = .022).

CONCLUSION

In patients with PP ICDs, GEH is independently associated with appropriate ICD therapies. The SVG vector points in distinctly different directions in patients with 2 competing outcomes.

摘要

背景

全球电异质性(GEH)与普通人群中的心脏性猝死有关。其在接受原发性预防(PP)植入式心脏复律除颤器(ICD)治疗的收缩性心力衰竭患者中的应用尚不清楚。

目的

本研究旨在探讨 GEH 是否与导致心力衰竭和 PP ICD 患者适当 ICD 治疗的持续性室性心动过速/心室颤动有关。

方法

我们进行了一项多中心回顾性队列研究。通过空间心室梯度(SVG)方向(方位和仰角)和幅度、QRS-T 角和 12 导联心电图的总和绝对值 QRST 积分来测量 GEH。使用特定病因的危险函数进行生存分析,比较了与 2 种竞争结果的关联强度:导致适当 ICD 治疗的持续性室性心动过速/心室颤动和无适当 ICD 治疗的全因死亡。

结果

我们分析了 2668 名患者(平均年龄 63 ± 12 岁;624 名(23%)女性;78%为白人;43%为非缺血性心肌病;左心室射血分数为 28% ± 11%,来自 6 所学术医疗中心)。在校正人口统计学、临床、设备和传统心电图特征后,SVG 抬高(每 1SD 增加 1.14;95%置信区间 [CI] 1.04-1.25;P =.004)、SVG 方位(每 1SD 增加 1.12;95%CI 1.01-1.24;P =.039)、SVG 幅度(每 1SD 增加 0.75;95%CI 0.66-0.85;P <.0001)和 QRS-T 角(每 1SD 增加 1.21;95%CI 1.08-1.36;P =.001)与适当 ICD 治疗有关。总和绝对值 QRST 积分在梗死相关心肌病(HR 1.29;95%CI 1.04-1.60)和非缺血性心肌病(HR 0.78;95%CI 0.62-0.96)(P =.022)中的关联不同。

结论

在接受 PP ICD 治疗的患者中,GEH 与适当的 ICD 治疗独立相关。SVG 向量在两种竞争结果患者中指向明显不同的方向。